# OnCo record cd19 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/cd19/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "cd19" ;
  schema:name "CD19"@en ;
  schema:description "CD19 is a marker on B cells and B-cell cancers, and was the target of the first CAR-T therapies ever approved."@en ;
  schema:url <https://onco.cc/targets/cd19/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/CD19>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1633>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000177455>, <https://www.uniprot.org/uniprotkb/P15391/entry>, <https://www.ncbi.nlm.nih.gov/gene/930> ;
  owl:sameAs <http://www.wikidata.org/entity/Q798033> ;
  schema:citation <https://en.wikipedia.org/wiki/CD19>, <https://doi.org/10.1158/2159-8290.CD-15-1020>, <https://doi.org/10.1182/blood.2021010930> ;
  onco:tag "car-t-target" ;
  schema:alternateName "CD19" ;
  onco:targetClass "surface-antigen" ;
  onco:firstDescribed "1988"^^xsd:gYear ;
  onco:related <https://onco.cc/biomarkers/cd19-expression/> ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/mk-1045/>, <https://onco.cc/drugs/rondecabtagene-autoleucel/>, <https://onco.cc/drugs/azd0486/>, <https://onco.cc/drugs/zamtocabtagene-autoleucel/>, <https://onco.cc/drugs/tc011/>, <https://onco.cc/drugs/englumafusp-alfa/>, <https://onco.cc/drugs/crc01/>, <https://onco.cc/drugs/gc012f/>, <https://onco.cc/drugs/jnj-90014496/>, <https://onco.cc/drugs/ctx112/>, <https://onco.cc/drugs/at101/>, <https://onco.cc/drugs/cd19-t-hank/>, <https://onco.cc/drugs/tbi-1501/> ;
  onco:companies <https://onco.cc/companies/capstan-therapeutics/>, <https://onco.cc/companies/century-therapeutics/>, <https://onco.cc/companies/cullinan-therapeutics/>, <https://onco.cc/companies/iksuda-therapeutics/>, <https://onco.cc/companies/imugene/>, <https://onco.cc/companies/janux-therapeutics/>, <https://onco.cc/companies/kelonia-therapeutics/>, <https://onco.cc/companies/kernal-biologics/>, <https://onco.cc/companies/lyell-immunopharma/>, <https://onco.cc/companies/poseida-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06948981/>, <https://onco.cc/trials/nct06179524/>, <https://onco.cc/trials/nct05326243/>, <https://onco.cc/trials/nct04684147/>, <https://onco.cc/trials/nct07284433/> .